372 related articles for article (PubMed ID: 36817420)
1. Pathogenesis and treatment of Sjogren's syndrome: Review and update.
Zhan Q; Zhang J; Lin Y; Chen W; Fan X; Zhang D
Front Immunol; 2023; 14():1127417. PubMed ID: 36817420
[TBL] [Abstract][Full Text] [Related]
2. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
3. Sjögren's syndrome: Old and new therapeutic targets.
Mavragani CP; Moutsopoulos HM
J Autoimmun; 2020 Jun; 110():102364. PubMed ID: 31831255
[TBL] [Abstract][Full Text] [Related]
4. A cohort study of T helper 17 cell-related cytokine levels in tear samples of systemic lupus erythematosus and Sjögren's syndrome patients with dry eye disease.
Peng X; Lu Y; Wei J; Lin T; Lu Q; Liu Q; Ting WJ
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):159-165. PubMed ID: 34596026
[TBL] [Abstract][Full Text] [Related]
5. Total glucosides of paeony (TGP) alleviates Sjogren's syndrome through inhibiting inflammatory responses in mice.
Li B; Liu G; Liu R; He S; Li X; Huang L; Wang Z; Li Y; Chen Y; Yin H; Fang W
Phytomedicine; 2020 Jun; 71():153203. PubMed ID: 32402913
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis.
Yao G; Qi J; Liang J; Shi B; Chen W; Li W; Tang X; Wang D; Lu L; Chen W; Shi S; Hou Y; Sun L
Theranostics; 2019; 9(26):8253-8265. PubMed ID: 31754394
[No Abstract] [Full Text] [Related]
7. Mechanisms and New Strategies for Primary Sjögren's Syndrome.
Mavragani CP
Annu Rev Med; 2017 Jan; 68():331-343. PubMed ID: 28099084
[TBL] [Abstract][Full Text] [Related]
8. Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells.
Li B; Xing Y; Gan Y; He J; Hua H
Stem Cell Res Ther; 2021 Aug; 12(1):478. PubMed ID: 34446113
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren's Syndrome-Like Disease.
Abughanam G; Elkashty OA; Liu Y; Bakkar MO; Tran SD
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557796
[TBL] [Abstract][Full Text] [Related]
10. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
[TBL] [Abstract][Full Text] [Related]
11. Advances in the understanding and treatment of systemic complications in Sjögren's syndrome.
Brito-Zerón P; Ramos-Casals M;
Curr Opin Rheumatol; 2014 Sep; 26(5):520-7. PubMed ID: 25050925
[TBL] [Abstract][Full Text] [Related]
12. Insights into Microbiota in Sjögren's Syndrome.
Mieliauskaitė D; Kontenis V
Medicina (Kaunas); 2023 Sep; 59(9):. PubMed ID: 37763780
[TBL] [Abstract][Full Text] [Related]
13. The future of B cell-targeted therapies in Sjögren's syndrome.
Cornec D; Saraux A; Devauchelle-Pensec V; Clodic C; Pers JO
Immunotherapy; 2013 Jun; 5(6):639-46. PubMed ID: 23725286
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome. Controversies and progress.
Fox RI
Clin Lab Med; 1997 Sep; 17(3):431-44. PubMed ID: 9316767
[TBL] [Abstract][Full Text] [Related]
15. Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjögren's syndrome with a special emphasis on BAFF.
Szodoray P; Jellestad S; Alex P; Zhou T; Wilson PC; Centola M; Brun JG; Jonsson R
J Clin Immunol; 2004 Nov; 24(6):600-11. PubMed ID: 15622444
[TBL] [Abstract][Full Text] [Related]
16. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment.
Routsias JG; Goules JD; Charalampakis G; Tzima S; Papageorgiou A; Voulgarelis M
Semin Arthritis Rheum; 2013 Oct; 43(2):178-86. PubMed ID: 23816048
[TBL] [Abstract][Full Text] [Related]
17. Clinical and immunological consequences of total glucosides of paeony treatment in Sjögren's syndrome: A randomized controlled pilot trial.
Zhou Y; Jin L; Kong F; Zhang H; Fang X; Chen Z; Wang G; Li X; Li X
Int Immunopharmacol; 2016 Oct; 39():314-319. PubMed ID: 27517517
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjögren's syndrome.
Whittingham S; Mackay IR; Tait BD
Aust N Z J Med; 1983 Dec; 13(6):565-70. PubMed ID: 6609699
[TBL] [Abstract][Full Text] [Related]
19. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome.
Szodoray P; Jonsson R
Scand J Immunol; 2005 Nov; 62(5):421-8. PubMed ID: 16305638
[TBL] [Abstract][Full Text] [Related]
20. Stem cells from exfoliated deciduous teeth transplantation ameliorates Sjögren's syndrome by secreting soluble PD-L1.
Yang N; Liu X; Chen X; Yu S; Yang W; Liu Y
J Leukoc Biol; 2022 May; 111(5):1043-1055. PubMed ID: 34622984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
